Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…
Biotechnology
DK, Bagsvaerd [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Novo Nordisk A/S (NVO) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 33,602.38 | 13,549.18 | 436.02 | -777.79 | -1,224.07 | 0.00 | 24.2387 | 46.16 | -0.0449 | -19.5209 | -0.08 | -0.10 | 7.0795 | - - | ||
| Maximum | - - | - - | - - | 1,535,067.00 | 609,984.00 | 35,800.00 | 9,826.00 | 5,421.00 | 0.02 | 1,336.3467 | 2,849.43 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -132.82 | -16.7400 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Sarepta Therapeutics, Inc. SRPT | 114.23 | 3.73 3.38% | 872 vs. 866 | 10,911.00 | 413.00 | 36.00 | -284.00 | -4,410.00 | 0.3800 | 83.5325 | 0.0000 | 0.8777 | 0.0874 | 0.0376 | 0.0112 | 2.9737 | 95.00 | ||
| Seagen Inc. SGEN | 228.74 | -0.16 -0.07% | 19,392 vs. 1,634 | 43,154.00 | 648.00 | -215.00 | -79.00 | -2,756.00 | -1.1500 | -46.2406 | 0.0000 | 0.7452 | -0.3327 | -0.0846 | -0.0594 | 1.9572 | 188.00 | ||
| Moderna, Inc. MRNA | 41.11 | 2.86 7.48% | 13,325 vs. 6,548 | 15,819.00 | 167.00 | -1,175.00 | -1,185.00 | 12,431.00 | -3.0800 | -8.5828 | 0.0000 | 0.2096 | -7.0359 | -0.0917 | -0.0702 | 3.7508 | 384.00 | ||
| TG Therapeutics, Inc. TGTX | 35.07 | 0.52 1.51% | 2,573 vs. 3,764 | 5,459.00 | 63.00 | -10.00 | -8.00 | -1,525.00 | -0.0732 | -50.4229 | 0.0000 | 0.9130 | -0.1687 | -0.0669 | -0.0287 | 2.7564 | 155.00 | ||
| Madrigal Pharmaceuticals, Inc. MDGL | 347.45 | 18.21 5.53% | 532 vs. 380 | 7,578.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.0000 | 0.0000 | 0.0000 | -0.1734 | -0.1363 | 9.2623 | 21.00 | ||
| Vertex Pharmaceuticals Incorporated VRTX | 450.97 | 0.60 0.13% | 1,264 vs. 1,124 | 116,137.00 | 2,687.00 | 1,099.00 | 1,058.00 | 11,242.00 | 4.2600 | 24.6835 | 0.0000 | 0.8725 | 0.4092 | 0.0593 | 0.0460 | 3.1520 | 257.00 | ||
| Regeneron Pharmaceuticals, Inc. REGN | 738.00 | -6.50 -0.87% | 1,028 vs. 703 | 79,757.00 | 3,145.00 | 722.00 | 1,350.00 | 27,982.00 | 6.7000 | 36.1813 | 0.0000 | 0.8258 | 0.2296 | 0.0267 | 0.0210 | 4.3960 | 108.00 | ||
| Intellia Therapeutics, Inc. NTLA | 14.30 | 0.50 3.62% | 2,353 vs. 2,217 | 1,456.00 | 28.00 | -107.00 | -123.00 | -1,765.00 | -1.1200 | -6.0491 | 0.0000 | 0.9132 | -3.7130 | -0.1037 | -0.0853 | 8.4537 | 101.00 | ||
| CRISPR Therapeutics AG CRSP | 47.88 | 1.59 3.43% | 1,496 vs. 1,277 | 4,086.00 | 0.00 | -116.00 | 109.00 | -1,116.00 | -1.4300 | -11.9580 | 0.0000 | -101.7758 | -231.3313 | -0.0559 | -0.0478 | 17.7168 | 85.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| Novo Nordisk A/S NVO | 105.06 | 2.43 2.37% | 5,405 vs. 4,659 | 473,530.00 | 65,349.00 | 25,407.00 | 5,305.00 | 99,050.00 | 5.7000 | 38.8598 | 0.0072 | 0.8483 | 0.3888 | 0.2569 | 0.0850 | 0.4372 | 4,507.00 | ||
| CureVac N.V. CVAC | 2.66 | 0.10 3.91% | 473 vs. 471 | 596.00 | 12.00 | -70.00 | -101.00 | -1,636.00 | -0.3100 | -2.2038 | 0.0000 | -2.3694 | -5.7022 | -0.1579 | -0.1022 | 2.0371 | 224.00 | ||
| BioMarin Pharmaceutical Inc. BMRN | 64.26 | 0.81 1.28% | 1,195 vs. 1,759 | 12,246.00 | 648.00 | 88.00 | 12.00 | -532.00 | 0.4700 | 46.3847 | 0.0000 | 0.7850 | 0.1366 | 0.0175 | 0.0129 | 1.5477 | 190.00 | ||
| Alnylam Pharmaceuticals, Inc. ALNY | 244.89 | -1.91 -0.77% | 450 vs. 862 | 31,586.00 | 494.00 | -65.00 | -94.00 | -7,075.00 | -0.5200 | -73.3326 | 0.0000 | 0.8665 | -0.1334 | 0.3007 | -0.0172 | 2.8593 | 128.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.